The Marginal Zone Lymphoma Treatment Market is expected to grow at a CAGR of 6% during the forecast period 2022-2028. Marginal zone lymphoma is the third most common subtype of non-Hodgkin’s lymphoma (NHL). The most common subtype of NHL is diffuse large B-cell lymphoma (DLBCL). Marginal zone lymphoma is a cancer of the lymphatic system. […]
